The knockdown of CCCTC binding factor (CTCF) or dipeptidyl peptidase-4 (DPP4) in HFD-fed mice and PA + LPS-treated AML-12 cells yields similar effects to Gardenoside treatment, while CTCF overexpression counteracted this alteration. Here, DPP4 is linked to acute myeloid leukemia.